ISPC
ISPC
NASDAQ · Health Care

Ispecimen Inc

$0.15
+0.01 (+4.93%)
As of Mar 31, 5:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
134.88M
Net Income
-181,434,968
Gross Margin
42.9%
Profit Margin
-134.5%
Rev Growth
-5.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 42.9% 42.9% 46.6% 46.6%
Operating Margin -137.0% -123.3% 15.9% 13.1%
Profit Margin -134.5% -127.8% 10.7% 14.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 134.88M 143.29M 890.1K 703.7K
Gross Profit 57.88M 61.49M 415.1K 328.2K
Operating Income -184,774,829 -176,667,742 141.2K 92.5K
Net Income -181,434,968 -173,474,419 95.2K 101.7K
Gross Margin 42.9% 42.9% 46.6% 46.6%
Operating Margin -137.0% -123.3% 15.9% 13.1%
Profit Margin -134.5% -127.8% 10.7% 14.5%
Rev Growth -5.9% -5.9% +8.3% +9.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.46M 1.43M
Total Equity 1.24M 1.20M
D/E Ratio 1.18 1.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -178,599,128 -180,249,837 175.3K 162.6K
Free Cash Flow 124.9K 90.2K